A Conjugate Composed of Nerve Growth Factor Coupled to a Non-toxic Derivative of Clostridium botulinum Neurotoxin Type A can Inhibit Neurotransmitter Release in Vitro

References

• Ahnert-Hilger G., Weller U., Dauzenroth M. E., Habermann E., Gratzl M. The tetanus toxin light chain inhibits exocytosis. FEBS Lett 1989; 242: 245–248
   PubMed Web of Science ®Google Scholar
• Barbacid M. The Trk family of neurotrophin receptors. J. Neurobiol 1994; 25: 1386–1403
   PubMedGoogle Scholar
• Benedetti M., Levi A., Chao M. V. Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc. Natl. Acad. Sci. USA 1994; 90: 7859–7863
   Google Scholar
• Blasi J., Chapman E. R., Link E., Binz T., Yamasaki S., De Camilli P., Sudhof T. C., Niemann H., Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993; 365: 160–163
   PubMed Web of Science ®Google Scholar
• Bocchini V. The nerve growth factor. Amino acid composition and physicochemical properties. Eur. J. Biochem 1970; 15: 127–131
   PubMedGoogle Scholar
• Boyd R. S., Duggan M. J., Shone C. C., Foster K. A. The effect of botulinum neurotoxins on the release of insulin from the insulinoma cell lines HIT-5 and RINm5F. J. Biol. Chem 1995; 270: 18216–18218
   PubMedGoogle Scholar
• Davies A. M. Cell death and the trophic requirements of developing sensory neurons. Sensory Neurons : Diversity, Development, and Plasticity, S. A. Scott. Oxford University Press, New York 1992; 194–214
   Google Scholar
• Ehlers M. D., Kaplan D. R., Price D. L., Koliatos V. E. NGF-stimulated retrograde transport of trkA in the mammalian nervous system. J. Cell Biol 1995; 130: 149–156
   PubMedGoogle Scholar
• Granholm A.-C., Albeck D., Backman C., Curtis M., Ebendal T., Friden P., Henry M., Hoffer B., Kordower J., Rose G. M., Soderstrom S., Bartus R. T. A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review. Rev. Neurosci 1998; 9: 31–55
   PubMed Web of Science ®Google Scholar
• Greene L. A., Tischler A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 1976; 73: 2424–2428
   PubMed Web of Science ®Google Scholar
• Hallis B., James B. A.F., Shone C. C. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities. J. Clin. Microbiol 1996; 34: 1934–1938
   PubMed Web of Science ®Google Scholar
• Heckers S., Ohtake T., Wiley R. G., Lappi D. A., Geula C., Mesulam M. M. Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J. Neurosci 1994; 14: 1271–1289
   PubMedGoogle Scholar
• Hoch D. H., Romero M. M., Ehrlich B. E., Finkelstein A., DasGupta B. R., Simpson L. L. Channels formed by botulinum, tetanus, and diptheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc. Natl. Acad. Sci 1985; 82: 1692–1696
   PubMed Web of Science ®Google Scholar
• Imaizumi K., Kudo Y., Shiosaka S., Lee Y., Ikeda M., Ohta H., Matano S., Shoji M., Honjoh T., Tohyama M. Specific cholinergic destruction in the basal magnocellular nucleus and impaired passive avoidance behaviour in rodents. Brain Res 1991; 551: 36–43
   PubMedGoogle Scholar
• Johnson E. M., Jr., Taniuchi M., Clark H. B., Springer J. E., Koh S., Tayrien M. W., Loy R. Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system. J. Neurosci 1987; 7: 923–929
   PubMed Web of Science ®Google Scholar
• Oyler G. A., Higgins G. A., Hart R. A., Battenberg E., Billingsley M., Bloom F. E., Wilson M. C. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal sub-populations. J. Cell Biol 1989; 109: 3039–3052
   PubMed Web of Science ®Google Scholar
• Sandvig K., Olsnes S. Diptheria toxin entry into cells is facilitated by low pH. J. Cell Biol 1980; 87: 828–832
   PubMedGoogle Scholar
• Schiavo G., Papini E., Genna G., Montecucco C. An intact interchain disulfide bond is required for the neuro-toxicity of tetanus toxin. Infect. Immun 1990; 58: 4136–4141
   PubMed Web of Science ®Google Scholar
• Simpson L. L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 1981; 33: 155–188
   PubMed Web of Science ®Google Scholar
• Shone C. C., Hambleton P., Melling J. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. Eur. J. Biochem 1985; 151: 75–82
   PubMedGoogle Scholar
• Shone C. C., Hambleton P., Melling J. A 50–kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles. Eur. J. Biochem 1987; 167: 175–180
   PubMedGoogle Scholar
• Shone C. C., Melling J. Inhibition of calcium-dependent release of noradrenaline from PC2 cells by botulinum type-A neurotoxin. Long-term effects of the neurotoxin on intact cells. Eur. J. Biochem 1992; 207: 1009–1016
   PubMedGoogle Scholar
• Sollner T., Whiteheart S. W., Brunner M., Erdjument Bromaga H., Geromanos S., Tempst P., Rothman J. E. SNAP receptors implicated in vesicle targeting and fusion. Nature 1993; 362: 318–324
   PubMed Web of Science ®Google Scholar
• Stockel K., Schwab M., Thoenen H. Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons. Brain Rex 1975; 99: 1–16
   PubMedGoogle Scholar